Cellu Tissue Holdings, a North American producer of private label and value retail tissue products, filed on Friday with the SEC to raise up to $125 million in an initial public offering. The Alpharetta, GA-based company, which was founded in 1984 and booked $528 million in sales over the last 12 months, plans to list on the NYSE under the symbol CLU. Goldman Sachs and J.P. Morgan are the lead underwriters on the deal. No pricing terms were disclosed.
